论文部分内容阅读
The emergence and spread of antibiotic resistance represent a severe global issue.New drug targets and novel lead compounds that exempt from cross-resistance to existing drugs are urgently needed.LspA,a key enzyme involved in posttranslational processing of bacterial lipoprotein,looms as one of the new targets for antibacterial drugdiscovery.